INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 4 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,025 | +61.9% | 55,300 | -3.5% | 0.00% | 0.0% |
| Q2 2023 | $633 | -19.3% | 57,300 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $784 | +77.4% | 58,400 | +63.1% | 0.00% | – |
| Q4 2022 | $442 | -100.0% | 35,800 | -76.4% | 0.00% | -100.0% |
| Q3 2022 | $2,114,000 | +117.5% | 151,600 | +115.3% | 0.00% | +100.0% |
| Q2 2022 | $972,000 | +24.8% | 70,400 | +47.0% | 0.00% | 0.0% |
| Q1 2022 | $779,000 | -61.0% | 47,900 | -61.0% | 0.00% | -50.0% |
| Q4 2021 | $2,000,000 | +194.6% | 122,800 | +269.9% | 0.00% | +100.0% |
| Q3 2021 | $679,000 | -0.4% | 33,200 | -2.9% | 0.00% | 0.0% |
| Q2 2021 | $682,000 | +91.0% | 34,200 | +21964.5% | 0.00% | 0.0% |
| Q1 2021 | $357,000 | -85.4% | 155 | -84.3% | 0.00% | -66.7% |
| Q4 2020 | $2,440,000 | +156.0% | 988 | +329.6% | 0.00% | +200.0% |
| Q3 2020 | $953,000 | -43.8% | 230 | -35.0% | 0.00% | -66.7% |
| Q2 2020 | $1,696,000 | +21.9% | 354 | +60.2% | 0.00% | +50.0% |
| Q1 2020 | $1,391,000 | -75.2% | 221 | -51.2% | 0.00% | -83.3% |
| Q4 2019 | $5,613,000 | +126.8% | 453 | +21.4% | 0.01% | +71.4% |
| Q3 2019 | $2,475,000 | +14.0% | 373 | +36.6% | 0.01% | +16.7% |
| Q2 2019 | $2,172,000 | -13.7% | 273 | +21.3% | 0.01% | -14.3% |
| Q1 2019 | $2,516,000 | -12.4% | 225 | -21.1% | 0.01% | -12.5% |
| Q4 2018 | $2,872,000 | -3.3% | 285 | +21.3% | 0.01% | -20.0% |
| Q3 2018 | $2,969,000 | +76.1% | 235 | +16.9% | 0.01% | +42.9% |
| Q2 2018 | $1,686,000 | +18633.3% | 201 | +402.5% | 0.01% | – |
| Q1 2018 | $9,000 | -50.0% | 40 | -85.0% | 0.00% | -100.0% |
| Q4 2017 | $18,000 | -71.9% | 267 | -25.4% | 0.00% | -66.7% |
| Q3 2017 | $64,000 | +48.8% | 358 | +280.9% | 0.00% | +50.0% |
| Q2 2017 | $43,000 | -17.3% | 94 | -10.5% | 0.00% | 0.0% |
| Q1 2017 | $52,000 | -8.8% | 105 | -77.3% | 0.00% | -33.3% |
| Q4 2016 | $57,000 | -72.9% | 463 | -5.1% | 0.00% | -78.6% |
| Q3 2016 | $210,000 | +79.5% | 488 | +113.1% | 0.01% | +75.0% |
| Q2 2016 | $117,000 | -4.1% | 229 | +78.9% | 0.01% | -20.0% |
| Q1 2016 | $122,000 | +117.9% | 128 | -19.0% | 0.01% | +150.0% |
| Q4 2015 | $56,000 | -11.1% | 158 | +32.8% | 0.00% | -20.0% |
| Q3 2015 | $63,000 | -63.8% | 119 | +12.3% | 0.01% | -66.7% |
| Q2 2015 | $174,000 | -81.0% | 106 | -14.5% | 0.02% | -85.8% |
| Q1 2015 | $914,000 | +1532.1% | 124 | +87.9% | 0.11% | +1414.3% |
| Q4 2014 | $56,000 | – | 66 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 71,700 | $962,931 | 0.00% |
| JANE STREET GROUP, LLC | 104,000 | $1,396,720 | 0.00% |
| SIMPLEX TRADING, LLC | 58,400 | $784 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |